Use of extended-release fluvastatin perioperatively in patients undergoing vascular surgery who were not already taking a statin has led to a nearly 50% reduction in myocardial ischemia as well as reductions in cardiovascular death/nonfatal MI in the DECREASE III trial.
Heartwire
Source: http://www.medscape.com/pharmacists?src=rss
Medscape Pharmacists Headlines